Johnson & Johnson applying pharmaceuticals innovation model to med tech for rapid growth


Johnson & Johnson is restructuring its medtech business by implementing its successful pharmaceutical innovation model to medtech aiming faster growth of the medtech unit. In order to meet the ambitions of J&J’s medical device business unit, it has opened its arms to embrace collaboration and innovation with startups and academics. According to the business unit head, “J&J wants to be the partner of choice for companies big and small that are interested in bringing excellent solutions to patients and to healthcare systems around the world”. J&J is targeting to create “bidirectional” partnerships, such as its robotic surgery collaboration with Google. According to the global R&D head of J&J, the company is open to forging partnerships and developing world-leading technology and solutions.


(Image Courtesy: Midwest Service & Supply)

Recent Posts

Want to stay informed on major healthcare news in Latin America?

Subscribe to GHI Newsletter

Contact Us

Please feel free to contact us at any time. Send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search